Denosumab Now Dominant Therapy for Cancer-Associated Osteoporosis

Denosumab Now Dominant Therapy for Cancer-Associated Osteoporosis

Amid a substantial expansion of therapies in several drug classes for the treatment of osteoporosis,...
read more